156 related articles for article (PubMed ID: 7867636)
1. Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7.
van de Kamp M; Horstink LM; van den Hooven HW; Konings RN; Hilbers CW; Frey A; Sahl HG; Metzger JW; van de Ven FJ
Eur J Biochem; 1995 Feb; 227(3):757-71. PubMed ID: 7867636
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7.
van de Kamp M; van den Hooven HW; Konings RN; Bierbaum G; Sahl HG; Kuipers OP; Siezen RJ; de Vos WM; Hilbers CW; van de Ven FJ
Eur J Biochem; 1995 Jun; 230(2):587-600. PubMed ID: 7607233
[TBL] [Abstract][Full Text] [Related]
3. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis.
Ekkelenkamp MB; Hanssen M; Danny Hsu ST; de Jong A; Milatovic D; Verhoef J; van Nuland NA
FEBS Lett; 2005 Mar; 579(9):1917-22. PubMed ID: 15792796
[TBL] [Abstract][Full Text] [Related]
4. The tetracyclic lantibiotic actagardine. 1H-NMR and 13C-NMR assignments and revised primary structure.
Zimmermann N; Metzger JW; Jung G
Eur J Biochem; 1995 Mar; 228(3):786-97. PubMed ID: 7737178
[TBL] [Abstract][Full Text] [Related]
5. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.
Bierbaum G; Götz F; Peschel A; Kupke T; van de Kamp M; Sahl HG
Antonie Van Leeuwenhoek; 1996 Feb; 69(2):119-127. PubMed ID: 8775972
[TBL] [Abstract][Full Text] [Related]
6. Chemical synthesis and biological activity of analogues of the lantibiotic epilancin 15X.
Knerr PJ; van der Donk WA
J Am Chem Soc; 2012 May; 134(18):7648-51. PubMed ID: 22524291
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate.
Velásquez JE; Zhang X; van der Donk WA
Chem Biol; 2011 Jul; 18(7):857-67. PubMed ID: 21802007
[TBL] [Abstract][Full Text] [Related]
8. Assignment of the side-chain 1H and 13C resonances of interleukin-1 beta using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy.
Clore GM; Bax A; Driscoll PC; Wingfield PT; Gronenborn AM
Biochemistry; 1990 Sep; 29(35):8172-84. PubMed ID: 2261471
[TBL] [Abstract][Full Text] [Related]
9. Sequence determination of actagardine, a novel lantibiotic, by homonuclear 2D NMR spectroscopy.
Kettenring JK; Malabarba A; Vékey K; Cavalleri B
J Antibiot (Tokyo); 1990 Sep; 43(9):1082-8. PubMed ID: 2211371
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a new epidermin variant from two strains of Staphylococcus epidermidis--frequency of lantibiotic production in coagulase-negative staphylococci.
Israil AM; Jack RW; Jung G; Sahl HG
Zentralbl Bakteriol; 1996 Jul; 284(2-3):285-96. PubMed ID: 8837389
[TBL] [Abstract][Full Text] [Related]
11. NMR-based structural studies of the pNR-2/pS2 single domain trefoil peptide. Similarities to porcine spasmolytic peptide and evidence for a monomeric structure.
Polshakov VI; Frenkiel TA; Westley B; Chadwick M; May F; Carr MD; Feeney J
Eur J Biochem; 1995 Nov; 233(3):847-55. PubMed ID: 8521850
[TBL] [Abstract][Full Text] [Related]
12. Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5.
Bierbaum G; Szekat C; Josten M; Heidrich C; Kempter C; Jung G; Sahl HG
Appl Environ Microbiol; 1996 Feb; 62(2):385-92. PubMed ID: 8593044
[TBL] [Abstract][Full Text] [Related]
13. Assignment of the aliphatic 1H and 13C resonances of the Bacillus subtilis glucose permease IIA domain using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy.
Fairbrother WJ; Palmer AG; Rance M; Reizer J; Saier MH; Wright PE
Biochemistry; 1992 May; 31(18):4413-25. PubMed ID: 1581296
[TBL] [Abstract][Full Text] [Related]
14. The three-dimensional solution structure of the lantibiotic murein-biosynthesis-inhibitor actagardine determined by NMR.
Zimmermann N; Jung G
Eur J Biochem; 1997 Jun; 246(3):809-19. PubMed ID: 9219543
[TBL] [Abstract][Full Text] [Related]
15. Complete covalent structure of nisin Q, new natural nisin variant, containing post-translationally modified amino acids.
Fukao M; Obita T; Yoneyama F; Kohda D; Zendo T; Nakayama J; Sonomoto K
Biosci Biotechnol Biochem; 2008 Jul; 72(7):1750-5. PubMed ID: 18603791
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of plantaricin C, a novel lantibiotic.
Turner DL; Brennan L; Meyer HE; Lohaus C; Siethoff C; Costa HS; Gonzalez B; Santos H; Suárez JE
Eur J Biochem; 1999 Sep; 264(3):833-9. PubMed ID: 10491130
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional structure of the lantibiotic nisin in the presence of membrane-mimetic micelles of dodecylphosphocholine and of sodium dodecylsulphate.
Van Den Hooven HW; Doeland CC; Van De Kamp M; Konings RN; Hilbers CW; Van De Ven FJ
Eur J Biochem; 1996 Jan; 235(1-2):382-93. PubMed ID: 8631358
[TBL] [Abstract][Full Text] [Related]
18. Two unprecedented natural Aib-peptides with the (Xaa-Yaa-Aib-Pro) motif and an unusual C-terminus: structures, membrane-modifying and antibacterial properties of pseudokonins KL III and KL VI from the fungus Trichoderma pseudokoningii.
Rebuffat S; Goulard C; Hlimi S; Bodo B
J Pept Sci; 2000 Oct; 6(10):519-33. PubMed ID: 11071266
[TBL] [Abstract][Full Text] [Related]
19. The enigmatic mode of action of the lantibiotic epilancin 15X.
Wang X; Xu Y; Martin NI; Breukink E
Biochim Biophys Acta Biomembr; 2024 Mar; 1866(3):184282. PubMed ID: 38218577
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a bioactive lantibiotic produced by Staphylococcus warneri.
Petersen J; Boysen A; Fogh L; Tabermann K; Kofoed T; King A; Schrotz-King P; Hansen MC
Biol Chem; 2009; 390(5-6):437-44. PubMed ID: 19361283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]